State Of Wisconsin Investment Board Homology Medicines, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.55 - $3.01 $63,469 - $123,253	-40,948 Reduced 64.92%	22,122 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $100,538 - $225,669	-72,330 Reduced 53.42%	63,070 $124,000
Q1 2022 May 13, 2022	BUY	$2.6 - $4.17 $352,040 - $564,618	135,400 New	135,400 $412,000
Q2 2021 Aug 12, 2021	SELL	$6.02 - $9.64 $291,970 - $467,540	-48,500 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$8.92 - $13.29 $53,520 - $79,740	-6,000 Reduced 11.01%	48,500 $548,000
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $162,022 - $270,417	16,300 Added 42.67%	54,500 $583,000
Q1 2020 May 06, 2020	BUY	$12.5 - $22.04 $21,250 - $37,468	1,700 Added 4.66%	38,200 $594,000
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $181,302 - $274,044	12,300 Added 50.83%	36,500 $661,000
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $9,175 - $15,170	500 Added 2.11%	24,200 $474,000
Q1 2019 May 13, 2019	BUY	$19.76 - $29.57 $254,904 - $381,453	12,900 Added 119.44%	23,700 $657,000
Q3 2018 Nov 14, 2018	BUY	$15.54 - $22.86 $167,832 - $246,888	10,800 New	10,800 $247,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.